Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU health claim update

This article was originally published in The Tan Sheet

Executive Summary

The European Parliament and the Council of the EU must establish a positive list of approved health claims by Jan. 18, 2010. The Parliament and Council published the Nutrition and Health Claims Regulation in the Official Journal of the EU Jan. 18. The regulation states health claims must be based on scientific data and applies to product claims made on packaging or websites and would ban all claims related to rates or amounts of weight loss. The EU Council of Ministers adopted the regulation in October (1"The Tan Sheet," Oct. 16, 2006, In Brief)...

You may also be interested in...



EU health claims

The European Union Council of Ministers has adopted the Nutrition & Health Claims Regulation, which aims to harmonize regulation of health claims across the EU, according to an announcement by the council Oct 12. The adopted provisions would establish a positive list of approved health claims within three years of the regulation's publication in the Official Journal of the EU. Once the list is established, claims based on new scientific data will need approval from the European Food Safety Authority. The regulation would apply to product claims made on packaging or websites, and would ban all claims related to rates or amounts of weight loss. The regulation was adopted by the EU Parliament in May (1"The Tan Sheet" May 22, 2006, p. 9)...

Reimbursement Questions Jeopardize Hillrom/Bardy Merger

Hillrom is reconsidering its planned $375m acquisition of Bardy Diagnostics because of Novitas' plan to cut Medicare reimbursement for extended cardiac monitoring. Bardy is suing to complete the deal.

Boston Scientific Pays More Than $1Bn For Lumenis’ Surgical Laser Business

Lumenis’ surgical business includes the MOSES laser system for minimally invasive urology surgery which will complement Boston Scientific’s LithoVue ureteroscope.

Topics

UsernamePublicRestriction

Register

LL1134420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel